Rajnish Wellness is currently trading at Rs. 30.00, up by 1.10 points or 3.81% from its previous closing of Rs. 28.90 on the BSE.
The scrip opened at Rs. 29.50 and has touched a high and low of Rs. 30.30 and Rs. 29.50 respectively. So far 1028406 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 30.30 on 21-Dec-2022 and a 52 week low of Rs. 1.30 on 04-Jan-2022.
Last one week high and low of the scrip stood at Rs. 30.30 and Rs. 25.35 respectively. The current market cap of the company is Rs. 1152.71 crore.
The promoters holding in the company stood at 16.05%, while Institutions and Non-Institutions held 0.51% and 83.44% respectively.
Rajnish Wellness has received an in-principle approval from Eastern Railway for setting up of business centres at 500 plus stations across Tier I, II and III cities. Eastern Railway has evaluated the submitted unsolicited proposal by company for ‘developing business centre at various stations of Eastern Railway through entrepreneurship development program’ and the competent Railway authority has accorded an in principle approval to the submitted unsolicited Proposal. Rajnish has already submitted detailed project report (DPR), containing the Earning Plan which includes technical and financial details.
As per the said unsolicited proposal, the Kolkata headquartered eastern railway will offer a pre defined space to Rajnish Wellness for carrying out various business activities including distribution of medicines under its signature Franchisee model on upto 500 railways stations of Eastern Railways. With implementation of this project, the revenues and profitability will increase multi fold.
Rajnish has an excellent marketing network with huge presence on various e-commerce and online platforms which gives it edge over other such players. The company has presence in over 21 states with over 500 super stockists and 10000 distributors having presence in more than 1 lakh medical stores pan India.
Rajnish Wellness is a brand- manufacturing selling various ayurvedic medicinal products for personal sexual wellness of the consumers.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1814.50 |
| Dr. Reddys Lab | 1341.60 |
| Cipla | 1476.45 |
| Lupin | 2168.25 |
| Zydus Lifesciences | 972.30 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
